title: A novel bisindolylmaleimide derivative enhances functional recovery of heart after long-term hypothermic heart preservation.
abstract: BACKGROUND
  Functional recovery following heart transplantation mainly depends on the ability of preservative solution in providing the physical and biochemical environment so as to maintain the viability of the tissue during preservation and in reperfusion. Here we demonstrate the protective effects of a novel bisindolylmaleimide derivative, MS1, on enhancing the functional recovery of the heart following long-term hypothermic preservation when added to the preservative solution.
  
  
  METHODS
  After anesthesia and artificial ventilation, the hearts were rapidly isolated and perfused with Kreb's Henseleit buffer at 37 degrees C in working mode. After 30 minutes of perfusion, the hearts were arrested with cardioplegic solution and preserved in University of Wisconsin solution with (UW-MS1 group) or without MS1 (UW-Vehicle group) for 12 h at 4 degrees C. After 12 hours, the hearts were reperfused for 60 minutes.
  
  
  RESULTS
  MS1 treated hearts showed: a) significant recovery of cardiac functions (P<0.001), b) well-preserved myocardial ATP levels (P<0.001), c) less myocardial water content (P<0.01), d) reduced oxidative stress (P<0.001), e) less intracellular swelling and well-preserved mitochondria, and g) activation of cell survival cascades compared to the control hearts preserved in UW solution without MS1. In contrast, these protective effects of MS1 were abolished on opening the permeability transition pore before MS1 treatment.
  
  
  CONCLUSIONS
  These results altogether indicate the efficacy of this compound in protecting the myocardium against reperfusion injury and thus making this drug a clinically useful tool in patients undergoing reperfusion after cardiac surgeries.
authors.affiliation: Department of Thoracic & Cardiovascular Surgery, Kochi Medical School, Nankoku, Kochi, Japan.
authors.forename: Rajesh Gopalrao
authors.initials: RG
authors.lastname: Katare
authors.forename: Zou
authors.initials: Z
authors.lastname: Zhitian
authors.forename: Mikiko
authors.initials: M
authors.lastname: Sodeoka
authors.forename: Shiro
authors.initials: S
authors.lastname: Sasaguri
mesh_terms: D000241:Adenosine; D000493:Allopurinol; D000818:Animals; D005978:Glutathione; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D007035:Hypothermia; D007211:Indoles / Q000494:pharmacology*; D007328:Insulin; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008301:Maleimides / Q000494:pharmacology*; D008929:Mitochondria, Heart / Q000187:drug effects / Q000648:ultrastructure; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011887:Raffinose; D051381:Rats; D017208:Rats, Wistar
chemical_list: D007211:Indoles; D007328:Insulin; D008301:Maleimides; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D011493:Protein Kinase C; D005978:Glutathione; D000241:Adenosine; C088060:bisindolylmaleimide; D011887:Raffinose